CD4 T‐cell epitopes of human α B‐crystallin
暂无分享,去创建一个
D. Bourdette | A. Vandenbark | S. Subramanian | G. Burrows | Chunhe Wang | Y. Chou | D. Latocha | Dorian H Latocha
[1] G. Rosati,et al. Alpha B‐crystallin is not a dominant peripheral T‐cell autoantigen in multiple sclerosis amongst Sardinians , 2003, European journal of neurology.
[2] M. Gulley,et al. Clinical applications of BCR-ABL molecular testing in acute leukemia. , 2003, The Journal of molecular diagnostics : JMD.
[3] H. McFarland,et al. T cell response to 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in multiple sclerosis patients , 2002, Journal of Neuroimmunology.
[4] R. Henderson,et al. Identification of Naturally Processed CD4 T Cell Epitopes from the Prostate-Specific Antigen Kallikrein 4 Using Peptide-Based In Vitro Stimulation1 , 2002, The Journal of Immunology.
[5] R. Cisterna,et al. Non-radioactive PCR-SSCP with a single PCR step for detection of inhibitor resistant beta-lactamases in Escherichia coli. , 2002, Journal of microbiological methods.
[6] J. Ilonen,et al. HLA class II associated risk and protection against multiple sclerosis—a Finnish family study , 2002, Journal of Neuroimmunology.
[7] X. Montalban,et al. Specific Proliferation Towards Myelin Antigens in Patients with Multiple Sclerosis During a Relapse , 2002, Autoimmunity.
[8] Jorge R. Oksenberg,et al. The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease , 2001, Science.
[9] T. Wienker,et al. Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2. , 2000, Human immunology.
[10] K. Lundin,et al. Identification and HLA Restriction of Naturally Derived Th1-Cell Epitopes from the Secreted Mycobacterium tuberculosisAntigen 85B Recognized by Antigen-Specific Human CD4+T-Cell Lines , 2000, Infection and Immunity.
[11] J. Bajramovic,et al. Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis , 2000, Journal of Neuroimmunology.
[12] T. MacRae. Structure and function of small heat shock/α-crystallin proteins: established concepts and emerging ideas , 2000, Cellular and Molecular Life Sciences CMLS.
[13] J. Newcombe,et al. Presentation of αB-Crystallin to T Cells in Active Multiple Sclerosis Lesions: An Early Event Following Inflammatory Demyelination1 , 2000, The Journal of Immunology.
[14] P. Travers,et al. Encephalitogenic and immunogenic potential of the stress protein αB-crystallin in Biozzi ABH (H-2Ag7) mice , 2000, Journal of Neuroimmunology.
[15] John I. Clark,et al. Small heat-shock proteins and their potential role in human disease. , 2000, Current opinion in structural biology.
[16] C. Boog,et al. Tolerance controls encephalitogenicity of αB-crystallin in the Lewis rat , 2000, Journal of Neuroimmunology.
[17] L. Fugger,et al. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor , 1999, Nature Genetics.
[18] H. Link,et al. Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines , 1999, Journal of Neuroimmunology.
[19] W. Schaper,et al. Binding of the stress protein alpha B-crystallin to cardiac myofibrils correlates with the degree of myocardial damage during ischemia/reperfusion in vivo. , 1999, Journal of molecular and cellular cardiology.
[20] M. V. van Stipdonk,et al. EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis. , 1999, Journal of immunology.
[21] Don C. Wiley,et al. Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein , 1998, The Journal of experimental medicine.
[22] T. Olsson,et al. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis , 1998, Journal of Neuroimmunology.
[23] P. Travers,et al. T cells discriminate between differentially phosphorylated forms of alphaB-crystallin, a major central nervous system myelin antigen. , 1998, International immunology.
[24] H. McFarland,et al. T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects , 1998, Journal of Neuroimmunology.
[25] J. Strominger,et al. HLA-DP2: self peptide sequences and binding properties. , 1997, Journal of immunology.
[26] A. Ben-nun,et al. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions , 1997, European journal of immunology.
[27] P. Charukamnoetkanok,et al. Thymic expression of autoantigens correlates with resistance to autoimmune disease. , 1997, Journal of immunology.
[28] H. Lassmann,et al. Expression of αB-crystallin in glia cells during lesional development in multiple sclerosis , 1997, Journal of Neuroimmunology.
[29] L Steinman,et al. Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System , 1996, Cell.
[30] C. Goodyer,et al. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[31] C. Melief,et al. Recognition of peptides corresponding to the joining region of p210BCR-ABL protein by human T cells. , 1995, Leukemia.
[32] C. Polman,et al. The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis , 1995, Nature.
[33] H. Rammensee,et al. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. , 1994, Journal of immunology.
[34] C Oseroff,et al. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones , 1994, The Journal of experimental medicine.
[35] P. Kelly,et al. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. , 1993, Mayo Clinic proceedings.
[36] C. Hsieh,et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.
[37] D. Bourdette,et al. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis , 1992, Journal of Neuroimmunology.
[38] L. Ding,et al. Alpha B-crystallin exists as an independent protein in the heart and in the lens. , 1991, European journal of biochemistry.
[39] C. Brosnan,et al. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.
[40] Eric O Long,et al. HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals. , 1990, Journal of immunology.
[41] H. Weiner,et al. T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis , 1990, Nature.
[42] D. Mitchell,et al. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. , 1990, International immunology.
[43] D. Bourdette,et al. Response of human T lymphocyte lines to myelin basic protein: Association of dominant epitopes with HLA class II restriction molecules , 1989, Journal of neuroscience research.
[44] R. Sobel,et al. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. , 1989, Journal of immunology.
[45] P. Gregersen,et al. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules. , 1988, Journal of immunology.
[46] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.
[47] W. D. de Jong,et al. The primary structure of the B2 chain of human α‐crystallin , 1977 .
[48] H. McFarland,et al. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. , 1995, Critical reviews in clinical laboratory sciences.